CBAY Annual Working Capital
$366.96 M
+$244.33 M+199.24%
31 December 2023
Summary:
As of January 21, 2025, CBAY annual working capital is $366.96 million, with the most recent change of +$244.33 million (+199.24%) on December 31, 2023. During the last 3 years, it has risen by +$225.23 million (+158.92%).CBAY Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBAY Quarterly Working Capital
$366.96 M
-$61.03 M-14.26%
31 December 2023
Summary:
As of January 21, 2025, CBAY quarterly working capital is $366.96 million, with the most recent change of -$61.03 million (-14.26%) on December 31, 2023. Over the past year, it has dropped by -$61.03 million (-14.26%).CBAY Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBAY Working Capital Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +199.2% | -14.3% |
3 y3 years | +158.9% | +158.9% |
5 y5 years | +119.5% | +119.5% |
CBAY Working Capital High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time | at high | -14.3% |
CymaBay Therapeutics Working Capital History
Date | Annual | Quarterly |
---|---|---|
Dec 2023 | $366.96 M(+199.2%) | $366.96 M(-14.3%) |
Sept 2023 | - | $427.99 M(+107.6%) |
June 2023 | - | $206.18 M(+5.1%) |
Mar 2023 | - | $196.22 M(+60.0%) |
Dec 2022 | $122.63 M(-29.0%) | $122.63 M(-13.9%) |
Sept 2022 | - | $142.41 M(-7.6%) |
June 2022 | - | $154.05 M(-13.5%) |
Mar 2022 | - | $178.01 M(+3.1%) |
Dec 2021 | $172.73 M(+21.9%) | $172.73 M(+60.2%) |
Sept 2021 | - | $107.83 M(+2.8%) |
June 2021 | - | $104.85 M(-16.4%) |
Mar 2021 | - | $125.36 M(-11.5%) |
Dec 2020 | $141.73 M(-23.5%) | $141.73 M(-9.0%) |
Sept 2020 | - | $155.67 M(-5.4%) |
June 2020 | - | $164.62 M(-5.4%) |
Mar 2020 | - | $174.03 M(-6.1%) |
Dec 2019 | $185.29 M(+10.9%) | $185.29 M(-11.9%) |
Sept 2019 | - | $210.41 M(-10.2%) |
June 2019 | - | $234.39 M(-8.3%) |
Mar 2019 | - | $255.59 M(+52.9%) |
Dec 2018 | $167.15 M | $167.15 M(-11.4%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2018 | - | $188.62 M(-5.6%) |
June 2018 | - | $199.80 M(-6.3%) |
Mar 2018 | - | $213.26 M(+144.5%) |
Dec 2017 | $87.23 M(+846.4%) | $87.23 M(-2.7%) |
Sept 2017 | - | $89.63 M(+1424.1%) |
June 2017 | - | $5.88 M(-57.3%) |
Mar 2017 | - | $13.78 M(+49.5%) |
Dec 2016 | $9.22 M(-74.5%) | $9.22 M(-44.9%) |
Sept 2016 | - | $16.73 M(-26.0%) |
June 2016 | - | $22.62 M(-23.9%) |
Mar 2016 | - | $29.74 M(-17.7%) |
Dec 2015 | $36.13 M(+115.4%) | $36.13 M(-14.8%) |
Sept 2015 | - | $42.42 M(+114.7%) |
June 2015 | - | $19.76 M(-5.1%) |
Mar 2015 | - | $20.83 M(+24.2%) |
Dec 2014 | $16.77 M(-26.3%) | $16.77 M(-42.9%) |
Sept 2014 | - | $29.37 M(+151.5%) |
June 2014 | - | $11.68 M(-24.2%) |
Mar 2014 | - | $15.41 M(-32.3%) |
Dec 2013 | $22.75 M(-328.4%) | $22.75 M |
Dec 2012 | -$9.96 M | - |
FAQ
- What is CymaBay Therapeutics annual working capital?
- What is the all time high annual working capital for CymaBay Therapeutics?
- What is CymaBay Therapeutics annual working capital year-on-year change?
- What is CymaBay Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for CymaBay Therapeutics?
- What is CymaBay Therapeutics quarterly working capital year-on-year change?
What is CymaBay Therapeutics annual working capital?
The current annual working capital of CBAY is $366.96 M
What is the all time high annual working capital for CymaBay Therapeutics?
CymaBay Therapeutics all-time high annual working capital is $366.96 M
What is CymaBay Therapeutics annual working capital year-on-year change?
Over the past year, CBAY annual working capital has changed by +$244.33 M (+199.24%)
What is CymaBay Therapeutics quarterly working capital?
The current quarterly working capital of CBAY is $366.96 M
What is the all time high quarterly working capital for CymaBay Therapeutics?
CymaBay Therapeutics all-time high quarterly working capital is $427.99 M
What is CymaBay Therapeutics quarterly working capital year-on-year change?
Over the past year, CBAY quarterly working capital has changed by -$61.03 M (-14.26%)